In states that choose to end expanded Medicaid eligibility, fewer covered beneficiaries mean hospitals will see less ...

The recent decision by some US states to cover glucagon-like peptide-1 (GLP-1) agonists for obesity treatment marks a shift ...

Speaker Mike Johnson negotiated a number of last-minute changes to the megabill to ensure passage, including moving up the ...

Support grows among Americans for work requirements in Medicaid, but concerns arise as past implementations led to ...

Doctors, patients and health experts are bracing for massive coverage losses as House Republicans are poised to impose ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Hospitals, physicians, health insurers, long-term care providers and others warn of serious consequences for the healthcare ...

As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity. These states are: California, Connecticut, Indiana, Maryland, ...

New rules would restrict access to the low-income health insurance program, punish states covering undocumented children, and ...

() - Democrats representing Arizona in Congress are pointing to a new report as proof that people would lose health insurance ...

The U.S. House of Representatives passed the "one big beautiful bill" touted by President Donald Trump in the early hours of Thursday morning, a sweeping tax and immigration package that includes ...